Denali Therapeutics DNLI
NASDAQ DNLI
$19.73 -0.12 (-0.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Denali Therapeutics (DNLI) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Denali Therapeutics (DNLI) recorded Return on Capital Employed [ROCE] of -47.85% in Q3 2026, up 5.81 percentage points from -53.67% a year earlier and up 0.52 percentage points from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Denali Therapeutics reported Return on Capital Employed [ROCE] of -47.83%, down 5.88 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -54.05 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -41.95% in FY2024 (-25.94 pp), -16.00% in FY2023 (+15.89 pp), -31.90% in FY2022 (-5.63 pp) and -26.27% in FY2021 (-32.49 pp).
  • The Q3 2026 figure is the highest quarterly Return on Capital Employed [ROCE] since Q2 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in 1 of the last eight quarters, with an average year-over-year change of -12.62 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 22.78 percentage points in Q1 2024, against a drop of 36.53 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -48.37% (Q2 2026), -49.95% (Q1 2026) and -55.43% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn -47.85%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -47.85%
Jun 30, 2026 -48.37%
Mar 31, 2026 -49.95%
Dec 31, 2025 -55.43%
Sep 30, 2025 -53.67%
Jun 30, 2025 -47.31%
Mar 31, 2025 -41.86%
Dec 31, 2024 -37.15%
Sep 30, 2024 -35.23%
Jun 30, 2024 -32.76%
Mar 31, 2024 -15.07%
Dec 31, 2023 -17.60%
Sep 30, 2023 -14.12%
Jun 30, 2023 -12.67%
Mar 31, 2023 -37.85%
Dec 31, 2022 -34.77%
Sep 30, 2022 -34.75%
Jun 30, 2022 -30.32%
Mar 31, 2022 -28.50%
Dec 31, 2021 -28.20%
API Access

Denali Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEY